tirzepatide trial SURPASS-CVOT Published: Large Confirms CVD Efficacy of Tirzepatide after intensive lifestyle intervention

64% at 1 year and 84% at 2 years in those without diabetes Risk factors of discontinuation include lower income, older age, lower weight loss, cost, among others

Brain fog test for rheumatoid arthritis: identify symptoms, understand causes, and learn how to manage them.

Cules son sus precios.

Taking Topamax for weight loss may increase the risk of developing disordered eating behaviors

Conclusions Semaglutide 2.4 mg was cost-effective compared to D&E alone for patients with obesity (BMI30 kg/m2) and weight related comorbidities in Portugal, over a 40-year time horizon.

Symptomatic post-bariatric hypoglycemia (#PBH) affects ~8% of people who have undergone bariatric surgery